Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen

Chemotherapy-induced neutropenia (CIN) reportedly indicated better prognosis for some cancers. We retrospectively analyzed 150 evaluable metastatic gastric cancer (MGC) patients who had received first-line EOF5 (combination regimen of epirubicin, oxaliplatin and 5-day continuous infusion of 5-fluoro...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Rujiao, Huang, Mingzhu, Zhao, Xiaoying, Peng, Wei, Sun, Si, Cao, Jun, Ji, Dongmei, Wang, Chenchen, Guo, Weijian, Li, Jin, Yin, Jiliang, Zhu, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770753/
https://www.ncbi.nlm.nih.gov/pubmed/26528696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770753/
https://www.ncbi.nlm.nih.gov/pubmed/26528696

Ejemplares similares